QSkin data reveals the rising cost of skin cancer in Australia, with keratinocyte cancer and melanoma expenditure increasing sharply over a decade.
See how an AI skin cancer detection system analyses lesions, supports clinical decisions and helps clinics improve triage, consistency and screening capacity.
MoleMax Systems, a division of Macquarie Medical Systems, specialises in the development and production of dermatoscopic hardware and software, including dermatoscopes and the MoleMax Dermoscopy Software. These integrated solutions are designed for early clinical imaging sessions, analysis and comparisons of skin cancer, providing dermatologists with advanced tools for high-resolution imaging and analysis of skin lesions to improve patient outcomes.
Subscribe To The MoleMax Newsletter
